Mitosense

Great Falls, United States

Mitosense is a biotechnology company developing treatments for neurodegenerative diseases.

$3.5M raised

Jan 2024

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Mitosense raised?

Mitosense has raised $3.5M in total funding. The most recent round was Seed. The last funding was announced in January 2024.

Who are Mitosense's investors?

Mitosense's investors include Caydan Capital Partners.

Where is Mitosense headquartered?

Mitosense is headquartered in Great Falls, United States.

What does Mitosense do?

Mitosense is a biotechnology company developing treatments for neurodegenerative diseases.

What stage is Mitosense at?

Mitosense is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 22, 2024.

MLA

"Mitosense — Funding & Investors." VCBacked, January 22, 2024, https://www.vcbacked.co/company/mitosense. Accessed July 4, 2026.

APA

VCBacked. (2024). Mitosense — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/mitosense

Wikipedia (cite web)

{{cite web |title=Mitosense — Funding & Investors |url=https://www.vcbacked.co/company/mitosense |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 22, 2024.